ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 39215 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 39215; 2) Community: the network communities that were significantly associated with the response to NSC 39215; 3) Molecule: the relationships between components within communities and NSC 39215; 4) MDR: the compounds that were significantly associated with the NSC 39215.

NSC Compound Enrichment Correlation
NSC 174121 Methotrexate Derivative 0.0235234559682128 0.15524478
NSC 30637 Null 0.0235234559682128 0.55692747
NSC 317917 1-Propanone, 3-(dimethylamino)-2-[(dimethylamino)methyl]-1-(4-methoxyphenyl)-, dihydrochloride 0.0235234559682128 0.6264619
NSC 319447 Null 0.0235234559682128 0.23275127
NSC 335787 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide 0.0235234559682128 0.36660411
NSC 38535 2,6-Bis(4-morpholinylmethyl)cyclohexanone,dihydrochloride 0.0235234559682128 0.63066354
NSC 102810 D-ARABINOSE, 5-O-TRITYL-TRIBENZOATE 0.0238174255956147 0.40154304
NSC 142475 Null 0.0238174255956147 0.60093241
NSC 150311 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- 0.0238174255956147 0.41638649
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0238174255956147 0.13189617
Total:119  Current:67    [First] [Prev] [Next] [Last]